The National Institute on Drug Abuse (NIDA) recently shared that it is on the lookout for cannabis partners who can supply marijuana to research.
NIDA hopes to conduct research on all cannabis compounds, from THC and CBD to cannabinoids such as CBN, CBC, CBG and more.
Marijuana remains difficult to analyze because of its status as a Schedule I drug. But now that more U.S. states are legalizing the plant, it’s become increasingly important for authorities to develop a better understanding of cannabis and what it can do to the population on a long-term basis.
NIDA has historically had a conservative view regarding drugs, including marijuana. Still, it seems now is the time for the agency to expand its understanding of the drug. Magnifying its criteria and creating new partnerships with cannabis sources is just another step in painting a more accurate picture
Read full article on The Growth Op
